Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Clinical Cancer Research

• Publication date

  2010-11-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-10-0445PMID 21098695
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The 7th Edition of TNM in Lung Cancer: what now?

  2009cited by this paper
• Does surgery for primary non-small cell lung cancer and cerebral metastasis have any impact on survival?

  2009cited by this paper
• Circulating endothelial cells in oncology: pitfalls and promises

  2008cited by this paper
• Cancer Statistics, 2008

  2008cited by this paper
• Detection of mutations in EGFR in circulating lung-cancer cells.

  2008cited by this paper
• Circulating tumor cells in peripheral blood caused by surgical manipulation of non-small-cell lung cancer: pilot study using an immunocytology method

  2007cited by this paper
• Prognostic assessment after surgical resection for non-small cell lung cancer: experiences in 2083 patients.

  2007cited by this paper
• Circulating tumor cells (CTC) detection: clinical impact and future directions.

  2007influential reference
• CK19 mRNA expression measured by reverse-transcription polymerase chain reaction (RT-PCR) in the peripheral blood of patients with non-small cell lung cancer treated by chemo-radiation: an independent prognostic factor.

  2007cited by this paper
• Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection.

  2006cited by this paper
• CANCER PATIENTS

  2006cited by this paper
• Development of a membrane array‐based multimarker assay for detection of circulating cancer cells in patients with non‐small cell lung cancer

  2006cited by this paper
• Multigene real-time PCR detection of circulating tumor cells in peripheral blood of lung cancer patients.

  2006cited by this paper
• 4-year mortality in patients with non-small-cell lung cancer: development and validation of a prognostic index.

  2006cited by this paper
• Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes.

  2005cited by this paper
• Adjuvant chemotherapy of lung cancer: methodologic issues and therapeutic advances.

  2005cited by this paper
• Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study.

  2005cited by this paper
• Prognostic significance of micrometastasis in non-small-cell lung cancer.

  2004cited by this paper
• Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer

  2004influential reference
• Pathology and genetics of tumours of the lung , pleura, thymus and heart

  2004cited by this paper
• O-297 Quantification of free circulating DNA as a diagnostic marker in lung cancer

  2003cited by this paper
• Epidermal growth factor receptor mRNA in peripheral blood of patients with pancreatic, lung, and colon carcinomas detected by RT-PCR.

  2003cited by this paper
• Quantification of free circulating DNA as a diagnostic marker in lung cancer.

  2003cited by this paper
• Preoperative evidence of circulating tumor cells by means of reverse transcriptase-polymerase chain reaction for carcinoembryonic antigen messenger RNA is an independent predictor of survival in non-small cell lung cancer: a prospective study.

  2002cited by this paper
• Prognostic value of hyaluronan expression in non‐small‐cell lung cancer: Increased stromal expression indicates unfavorable outcome in patients with adenocarcinoma

  2001cited by this paper
• Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience.

  2001cited by this paper
• Resting and activated endothelial cells are increased in the peripheral blood of cancer patients.

  2001cited by this paper
• Detection of circulating carcinoma cells by telomerase activity

  2001cited by this paper
• Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA.

  2000cited by this paper
• Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells.

  2000cited by this paper
• The international system for staging lung cancer.

  2000cited by this paper
• Detection of circulating tumor cells by reverse transcriptase-polymerase chain reaction in patients with resectable non-small-cell lung cancer.

  1999cited by this paper
• The expression of basic fibroblast growth factor (bFGF) in tumor-associated stromal cells and vessels is inversely correlated with non-small cell lung cancer progression.

  1999cited by this paper
• Detection and quantitation of circulating cancer cells in the peripheral blood of lung cancer patients.

  1998influential reference
• Revisions in the International System for Staging Lung Cancer.

  1997cited by this paper
• Significant Changes In The Distribution Of Histologic Types Of Lung Cancer In Hong Kong

  1993cited by this paper
• Significant changes in the distribution of histologic types of lung cancer a review of 4928 cases

  1990cited by this paper
• The measurement of observer agreement for categorical data.

  1977cited by this paper
• World Journal of Surgical Oncology Management of Leiomyosarcomas of the Spermatic Cord: the Role of Reconstructive Surgery

  year unknowncited by this paper

• Serial changes in pleural lavage cytology during lung cancer surgery predict recurrence and pleural dissemination.

  2025cites this paper
• Prognostic Value of the Number of Circulating Tumor Cells in Patients with Metastatic Non-Small Cell Lung Cancer

  2025cites this paper
• Circulating tumor cells in lung cancer: Integrating stemness and heterogeneity to improve clinical utility.

  2025cites this paper
• Évaluation de la maladie résiduelle minime en oncologie thoracique

  2025cites this paper
• Nanotechnology-assisted lung cancer diagnosis: biomarkers and imaging

  2025cites this paper
• Circulating Hsp70: a tumor biomarker for lymph node metastases and early relapse in thoracic cancer

  2025cites this paper
• Liquid biopsy in lung cancer: The role of circulating tumor cells in diagnosis, treatment, and prognosis.

  2024cites this paper
• Overview of the Role of Liquid Biopsy in Non-small Cell Lung Cancer (NSCLC).

  2024cites this paper
• The capture of circulating tumor cells by Labyrinth system as a tool for early stage lung cancer detection

  2024cites this paper
• The detection of circulating tumor cells indicates poor therapeutic efficacy and prognosis in patients with nonsmall cell lung cancer: A systematic review and meta‐analysis

  2024cites this paper
• Recent advances in the use of liquid biopsy for the diagnosis and treatment of lung cancer

  2024cites this paper
• Unlocking the future of cancer diagnosis - promises and challenges of ctDNA-based liquid biopsies in non-small cell lung cancer.

  2024cites this paper
• The Role of Biomarkers in Lung Cancer Screening

  2024cites this paper
• Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors.

  2024cites this paper
• A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer

  2024cites this paper
• Longitudinal tracking of circulating rare events in the liquid biopsy of stage III–IV non-small cell lung cancer patients

  2024cites this paper
• Microfluidics engineering towards personalized oncology—a review

  2023cites this paper
• Monitoring with circulating tumor cells in the perioperative setting of patients with surgically treated stages I–IIIA NSCLC

  2023cites this paper
• A Review of Biomarkers and Their Clinical Impact in Resected Early-Stage Non-Small-Cell Lung Cancer

  2023cites this paper
• Liquid Biopsy in NSCLC: An Investigation with Multiple Clinical Implications

  2023cites this paper
• Circulating tumor cells (CTCs) and hTERT gene expression in CTCs for radiotherapy effect with lung cancer

  2023cites this paper
• Clinical and prognostic significance of detecting CEA, EGFR, LunX, c-met and EpCAM mRNA-positive cells in the peripheral blood, tumor-draining blood and bone marrow of non-small cell lung cancer patients

  2023cites this paper
• Different Liquid Biopsies for the Management of Non-Small Cell Lung Cancer in the Mutational Oncology Era

  2023cites this paper
• Mutational differences between primary cancer tissue and circulating tumor cells in early-stage non-small cell lung cancer

  2023cites this paper
• Liquid Biopsy as an Adjunct to Lung Screening Imaging.

  2023cites this paper
• The use of minimal residual disease in thoracic oncology: Gaps between promises and the on‐the‐ground reality of daily practice

  2023cites this paper
• An overview of current development and barriers on liquid biopsy in patients with early-stage non-small-cell Lung cancer

  2023cites this paper
• Circulating tumor cells dynamics during chemotherapy predict survival and response in advanced non-small-cell lung cancer patients

  2023cites this paper
• The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring

  2023cites this paper
• Utilization of Circulating Tumor Cells in the Management of Solid Tumors

  2023cites this paper
• Prognostic impact of circulating tumor cells in patients with soft‐tissue sarcomas: a prospective study

  2023cites this paper
• Liquid biopsies based on DNA methylation as biomarkers for the detection and prognosis of lung cancer

  2022cites this paper
• Circulating Tumor Cells as a Predictive Biomarker in Resectable Lung Cancer: A Systematic Review and Meta-Analysis

  2022cites this paper
• The Value of Circulating Tumor Cells in the Prognosis and Treatment of Pancreatic Cancer

  2022cites this paper
• Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer—An Update

  2022cites this paper
• Detection and Analysis of Human Cells Based on Artificial Neural Network

  2022cites this paper
• Identification of Atypical Circulating Tumor Cells with Prognostic Value in Metastatic Breast Cancer Patients

  2022cites this paper
• Tumor regionalization after surgery: Roles of the tumor microenvironment and neutrophil extracellular traps

  2022cites this paper
• One sample fits all: a microfluidic-assisted methodology for label-free isolation of CTCs with downstream methylation analysis of cfDNA in lung cancer.

  2022cites this paper
• Predictive Value of Circulating Tumor Cells Detected by ISET® in Patients with Non-Metastatic Prostate Cancer Undergoing Radical Prostatectomy

  2022cites this paper
• Molecular Pathology of Lung Cancer.

  2021cites this paper
• Significance of Circulating Tumor Cells in Nonsmall-Cell Lung Cancer Patients: Prognosis, Chemotherapy Efficacy, and Survival

  2021cites this paper
• Leukapheresis increases circulating tumour cell yield in non-small cell lung cancer, counts related to tumour response and survival

  2021cites this paper
• Comparison of hormonal receptor expression and HER2 status between circulating tumor cells and breast cancer metastases

  2021cites this paper
• New Advances in Liquid Biopsy Technologies for Anaplastic Lymphoma Kinase (ALK)—Positive Cancer

  2021cites this paper
• A novel combined fluorescent probe staining method for circulating tumor cell identification

  2021cites this paper
• The Liquid Biopsy for Lung Cancer: State of the Art, Limitations and Future Developments

  2021cites this paper
• Aneuploid Circulating Tumor Cells as a Predictor of Response to Neoadjuvant Chemotherapy in Non-Small Cell Lung Cancer

  2021cites this paper
• Clinical value of tumor-associated antigens and autoantibody panel combination detection in the early diagnostic of lung cancer

  2021cites this paper
• Clinical significance of circulating tumour cells and Ki-67 in renal cell carcinoma

  2021cites this paper
• Clinical Signi cance of Circulating Tumor Cells and Ki-67 in Renal Cell Carcinoma

  2021cites this paper
• Monitoring levels of vimentin-positive circulating cancer stem cells and tumor cells in patients with advanced EGFR-mutated non-small cell lung cancer.

  2021cites this paper
• Circulating Tumor Cells in the context Non-small Cell Lung Cancer

  2021cites this paper
• Subpopulations of Circulating Cells with Morphological Features of Malignancy Are Preoperatively Detected and Have Differential Prognostic Significance in Non-Small Cell Lung Cancer

  2021cites this paper
• Effective Drug Concentration and Selectivity Depends on Fraction of Primitive Cells

  2021cites this paper
• Toward a New Era for the Management of Circulating Tumor Cells.

  2021cites this paper
• Heterogeneous Circulating Tumor Cells in Sarcoma: Implication for Clinical Practice

  2021cites this paper
• The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer

  2021cites this paper
• Prospective multi-center validation of the detection of ALK rearrangements of circulating tumor cells for non-invasive longitudinal management of patients with advanced non-small cell lung cancer.

  2021cites this paper
• Nucleic Acid Tests for Clinical Translation.

  2021cites this paper
• Biomarkers and Lung Cancer Early Detection: State of the Art

  2021cites this paper
• Early Diagnosis and Screening for Lung Cancer.

  2021influential citation
• 18F-FDG PET/CT and circulating tumor cells in treatment-naive patients with non-small-cell lung cancer

  2021cites this paper
• Detection of Circulating Tumor Cells (CTCs) in Malignant Pleural Mesothelioma (MPM) with the “Universal” CTC-Chip and An Anti-Podoplanin Antibody NZ-1.2

  2020cites this paper
• Liquid biopsy is a valuable tool in the diagnosis and management of lung cancer

  2020cites this paper
• Clinical Utility of Combined Circulating Tumor Cell and Circulating Tumor DNA Assays for Diagnosis of Primary Lung Cancer

  2020cites this paper
• Tumor resection reduced circulating tumor cell dissemination

  2020cites this paper
• Circulating Tumor Cells and Metabolic Parameters in NSCLC Patients Treated with Checkpoint Inhibitors

  2020cites this paper
• A lab-on-a-disc platform enables serial monitoring of individual CTCs associated with tumor progression during EGFR-targeted therapy for patients with NSCLC

  2020cites this paper
• Utilidad clínica de la biopsia líquida para el diagnóstico y seguimiento de los pacientes con CPNM y EML4-ALK

  2020cites this paper
• Possible role of circulating tumor cells in early detection of lung cancer

  2020influential citation
• Clinical utility of liquid biopsy for the diagnosis and monitoring of EML4-ALK NSCLC patients

  2020cites this paper
• Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study.

  2020cites this paper
• Tumorspheres as an in vitro model for cancer stem-like cell characterization in non-small cell lung cancer. Prognostic implications

  2020cites this paper
• The emerging role of circulating tumor cells in cancer management.

  2020cites this paper
• Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages

  2020cites this paper
• Circulating Tumor Cells to Predict Microvascular Invasion and Dynamical Detection Indicate Prognosis of Hepatocellular Carcinoma

  2020cites this paper
• Isolation of Circulating Tumor Cells from Peripheral Blood Samples of Cancer Patients Using Microfluidic Technology

  2020cites this paper
• Anti-tumor e cacy of CKD-516 in combination with radiation in xenograft mouse model of lung squamous cell carcinoma

  2020cites this paper
• Application of liquid biopsy for surgical management of pancreatic cancer

  2020cites this paper
• Anti-tumor efficacy of CKD-516 in combination with radiation in xenograft mouse model of lung squamous cell carcinoma

  2020cites this paper
• Circulating Tumor Cells as Biomarkers in Pancreatic Cancer

  2020cites this paper
• Clinical utility of circulating tumor cells: an update

  2020cites this paper
• Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma

  2020cites this paper
• Circulating Tumor Cells Counting Act as a Potential Prognostic Factor in Cervical Cancer

  2020cites this paper
• Circulating Tumour Cells in Lung Cancer.

  2020cites this paper
• Circulating tumor cells detected only after surgery for non-small cell lung cancer: is it a predictor of recurrence?

  2020cites this paper
• Clinical Applications of Circulating Tumor DNA, Circulating Tumor Cells, and Exosomes as Liquid Biopsy-Based Tumor Biomarkers

  2020influential citation
• Efficient isolation and quantification of circulating tumor cells in non-small cell lung cancer patients using peptide-functionalized magnetic nanoparticles

  2020cites this paper
• Liquid biopsy for lung cancer screening: Usefulness of circulating tumor cells and other circulating blood biomarkers

  2020cites this paper
• A novel device to capture circulating tumor cells: Quantification and molecular analysis in lung cancer patients

  2020cites this paper
• A single‐view field filter device for rare tumor cell filtration and enumeration

  2020cites this paper
• Circulating Tumor Cell Detection in Lung Cancer: But to What End?

  2019cites this paper
• The potential of monitoring treatment response in non-small cell lung cancer using circulating tumour cells

  2019cites this paper
• Anti-tumor efficacy of CKD-516 in combination with radiation in xenograft lung cancer mouse model

  2019cites this paper
• Circulating Tumor Cells in Diagnosis and Treatment of Lung Cancer

  2019cites this paper
• Cytopathologic identification of circulating tumor cells (CTCs) in breast cancer: Application of size-based enrichment

  2019cites this paper
• Circulating tumor cells in patients with lung cancer: developments and applications for precision medicine.

  2019cites this paper
• Circulating Tumour Cells in Predictive Molecular Pathology: Focus on Drug-Sensitive Assays and 3D Culture

  2019cites this paper
• Diagnostic value of multiple tumor-associated autoantibodies in lung cancer

  2019cites this paper